Search Within

Imane El Dika

Formats
  1. Journal Article (36)
  2. Meeting Abstract (26)
  3. Book Section (2)
  4. Review (2)
  5. Miscellaneous (1)
Groups
  1. Department of Medicine (67)
  2. Gastrointestinal Oncology Service (67)
  3. Solid Tumor Oncology Division (67)
  4. Center for Pancreatic Cancer Research (53)
  5. Department of Pathology and Laboratory Medicine (34)
  6. Epidemiology and Biostatistics (33)

More Groups

People
  1. Ghassan Abou-Alfa (54)
  2. Eileen O'Reilly (36)
  3. James Harding (34)
  4. Marinela Capanu (23)
  5. Jinru Shia (22)
  6. Joanne Chou (21)

More People

Years
  1. 2025 (7)
  2. 2024 (5)
  3. 2023 (4)
  4. 2022 (12)
  5. 2021 (4)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (20)
  2. Cancer (5)
  3. Clinical Cancer Research (5)
  4. The Oncologist (5)
  5. Annals of Oncology (3)
  6. International Journal of Radiation Oncology, Biology, Physics (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Oxford University Press (10)
  3. American Association for Cancer Research (7)
  4. Wiley Blackwell (7)
  5. Elsevier Inc. (6)
  6. Springer (5)

More Publishers

Results (67)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies
    Journal Article

    Harding, J. J.; Do, R. K.; El Dika, I.; Hollywood, E.; Uhlitskykh, K.; Valentino, E.; Wan, P.; Hamilton, C.; Feng, X.; Johnston, A.; more...
    Cancer Chemotherapy and Pharmacology (2018)

    Fulltext@MSK | Save
  • Molecular landscape of fibrolamellar carcinoma (FLC): Beyond the DNAJB1-PRKACA chimera
    Meeting Abstract

    El Dika, I. H.; Capanu, M.; Berger, M. F.; Arcila, M. E.; Benayed, R.; Harding, J. J.; Rusek, M.; Valentino, E.; O'Reilly, E. M.; Saltz, L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A situation where hepatocellular carcinoma (HCC) may be more common in women than men: Clinical and genetic patterns of non risk-factored HCC
    Meeting Abstract

    El Dika, I. H.; Harding, J. J.; Capanu, M.; Berger, M. F.; Rebibo, D.; Rusek, M.; Chou, J. F.; O'Reilly, E. M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Advances in systemic therapy for hepatocellular carcinoma
    Book Section

    Harding, J. J.; Connell, L. C.; El Dika, I.; Abou-Alfa, G. K.
    In Jarnagin, W. R.; Allen, P. J.; Chapman, W. C.; D'Angelica, M. I.; DeMatteo, R. P.; Do, R. K. G.; Vauthey, J. N.; Blumgart, L. H. (Eds.) Blumgart's Surgery of the Liver, Biliary Tract and Pancreas. 6th ed (2017)

    Fulltext@MSK | Save
  • Treatment options after sorafenib failure in patients with hepatocellular carcinoma
    Journal Article

    El Dika, I.; Abou-Alfa, G. K.
    Clinical and Molecular Hepatology (2017)

    Fulltext@MSK | Save
  • The role (if any) of chemotherapy in hepatocellular carcinoma
    Journal Article

    El Dika, I.; Abou-Alfa, G. K.
    The Lancet Gastroenterology & Hepatology (2017)

    Fulltext@MSK | Save
  • Hepatocellular carcinoma in patients with HIV
    Journal Article

    El Dika, I.; Harding, J. J.; Abou-Alfa, G. K.
    Current Opinion in HIV and AIDS (2017)

    Fulltext@MSK | Save